{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:43:20Z","timestamp":1773287000573,"version":"3.50.1"},"reference-count":41,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2012,3,28]],"date-time":"2012-03-28T00:00:00Z","timestamp":1332892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Marine Drugs"],"abstract":"<jats:p>Hepatitis C virus (HCV) is a causative agent of acute and chronic hepatitis, leading to the development of hepatic cirrhosis and hepatocellular carcinoma. We prepared extracts from 61 marine organisms and screened them by an in vitro fluorescence assay targeting the viral helicase (NS3), which plays an important role in HCV replication, to identify effective candidates for anti-HCV agents. An ethyl acetate-soluble fraction of the feather star Alloeocomatella polycladia exhibited the strongest inhibition of NS3 helicase activity, with an IC50 of 11.7 \u00b5g\/mL. The extract of A. polycladia inhibited interaction between NS3 and RNA but not ATPase of NS3. Furthermore, the replication of the replicons derived from three HCV strains of genotype 1b in cultured cells was suppressed by the extract with an EC50 value of 23 to 44 \u00b5g\/mL, which is similar to the IC50 value of the NS3 helicase assay. The extract did not induce interferon or inhibit cell growth. These results suggest that the unknown compound(s) included in A. polycladia can inhibit HCV replication by suppressing the helicase activity of HCV NS3. This study may present a new approach toward the development of a novel therapy for chronic hepatitis C.<\/jats:p>","DOI":"10.3390\/md10040744","type":"journal-article","created":{"date-parts":[[2012,3,28]],"date-time":"2012-03-28T11:20:43Z","timestamp":1332933643000},"page":"744-761","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Inhibition of Hepatitis C Virus Replication and Viral Helicase by Ethyl Acetate Extract of the Marine Feather Star Alloeocomatella polycladia"],"prefix":"10.3390","volume":"10","author":[{"given":"Atsuya","family":"Yamashita","sequence":"first","affiliation":[{"name":"Department of Microbiology, Division of Medicine, Graduate School of Medicine and Engineering, University of Yamanashi, 1110 Shimokato, Chuo-shi, Yamanashi 409-3898, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazi Abdus","family":"Salam","sequence":"additional","affiliation":[{"name":"Radioisotope Center, The University of Tokyo, 2-11-16 Yayoi, Bunkyo-ku, Tokyo 113-0032, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Furuta","sequence":"additional","affiliation":[{"name":"Biomedical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), 1-1-1 Higashi, Tsukuba, Ibaraki 305-8566, Japan"},{"name":"Department of Life Science and Medical Bio-Science, Waseda University, 2-2 Wakamatsu-cho, Shinjuku-ku, Tokyo 162-8480, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyoshi","family":"Matsuda","sequence":"additional","affiliation":[{"name":"Biomedical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), 1-1-1 Higashi, Tsukuba, Ibaraki 305-8566, Japan"},{"name":"Department of Life Science and Medical Bio-Science, Waseda University, 2-2 Wakamatsu-cho, Shinjuku-ku, Tokyo 162-8480, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Fujita","sequence":"additional","affiliation":[{"name":"Biomedical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), 1-1-1 Higashi, Tsukuba, Ibaraki 305-8566, Japan"},{"name":"Department of Life Science and Medical Bio-Science, Waseda University, 2-2 Wakamatsu-cho, Shinjuku-ku, Tokyo 162-8480, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Tani","sequence":"additional","affiliation":[{"name":"Radioisotope Center, The University of Tokyo, 2-11-16 Yayoi, Bunkyo-ku, Tokyo 113-0032, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihisa","family":"Fujita","sequence":"additional","affiliation":[{"name":"University Education Center, University of the Ryukyus, Okinawa, 1 Senbaru, Nishihara, Okinawa 903-0213, Japan"},{"name":"Marine Learning Center, 2-95-101 Miyagi, Chatan, Okinawa 901-0113, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuusuke","family":"Fujimoto","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Division of Medicine, Graduate School of Medicine and Engineering, University of Yamanashi, 1110 Shimokato, Chuo-shi, Yamanashi 409-3898, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Tumor Virology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, 2-5-1 Shikata-cho, Okayama 700-8558, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Tumor Virology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, 2-5-1 Shikata-cho, Okayama 700-8558, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Maekawa","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, Faculty of Medicine, University of Yamanashi, Yamanashi, 1110 Shimokato, Chuo-shi, Yamanashi 409-3898, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Enomoto","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, Faculty of Medicine, University of Yamanashi, Yamanashi, 1110 Shimokato, Chuo-shi, Yamanashi 409-3898, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masamichi","family":"Nakakoshi","sequence":"additional","affiliation":[{"name":"Institute of Medical Chemistry, Hoshi University, Ebara 2-4-41, Shinagawa-ku, Tokyo 142-8501, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayoshi","family":"Tsubuki","sequence":"additional","affiliation":[{"name":"Institute of Medical Chemistry, Hoshi University, Ebara 2-4-41, Shinagawa-ku, Tokyo 142-8501, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Sekiguchi","sequence":"additional","affiliation":[{"name":"Biomedical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), 1-1-1 Higashi, Tsukuba, Ibaraki 305-8566, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4624-5359","authenticated-orcid":false,"given":"Satoshi","family":"Tsuneda","sequence":"additional","affiliation":[{"name":"Department of Life Science and Medical Bio-Science, Waseda University, 2-2 Wakamatsu-cho, Shinjuku-ku, Tokyo 162-8480, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyoshi","family":"Akimitsu","sequence":"additional","affiliation":[{"name":"Radioisotope Center, The University of Tokyo, 2-11-16 Yayoi, Bunkyo-ku, Tokyo 113-0032, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohiro","family":"Noda","sequence":"additional","affiliation":[{"name":"Biomedical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), 1-1-1 Higashi, Tsukuba, Ibaraki 305-8566, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Biology and Marine Science, University of the Ryukyus, Nishihara, Okinawa 903-0213, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9542-5188","authenticated-orcid":false,"given":"Kohji","family":"Moriishi","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Division of Medicine, Graduate School of Medicine and Engineering, University of Yamanashi, 1110 Shimokato, Chuo-shi, Yamanashi 409-3898, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2012,3,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.2174\/138161208784746770","article-title":"Epidemiology of HCV infection","volume":"14","author":"Baldo","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1002\/hep.1840360706","article-title":"Natural history of chronic hepatitis C","volume":"36","author":"Seeff","year":"2002","journal-title":"Hepatology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/rmv.542","article-title":"Host factors involved in the replication of hepatitis C virus","volume":"17","author":"Moriishi","year":"2007","journal-title":"Rev. Med. Virol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1128\/jvi.66.3.1476-1483.1992","article-title":"Internal ribosome entry site within hepatitis C virus RNA","volume":"66","author":"Iizuka","year":"1992","journal-title":"J. Virol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1128\/jvi.67.7.3835-3844.1993","article-title":"Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3\/4 and NS4\/5 junctions","volume":"67","author":"Bartenschlager","year":"1993","journal-title":"J. Virol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1006\/bbrc.1995.2447","article-title":"C-terminal domain of the hepatitis C virus NS3 protein contains an RNA helicase activity","volume":"215","author":"Kim","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1128\/jvi.68.6.3753-3760.1994","article-title":"Both NS3 and NS4A are required for proteolytic processing of hepatitis C virus nonstructural proteins","volume":"68","author":"Failla","year":"1994","journal-title":"J. Virol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2217\/fvl.09.7","article-title":"Helicase inhibitors as specifically targeted antiviral therapy for hepatitis C","volume":"4","author":"Belon","year":"2009","journal-title":"Future Virol."},{"key":"ref_9","first-page":"1","article-title":"The hepatitis C virus NS3 protein: a model RNA helicase and potential drug target","volume":"9","author":"Frick","year":"2007","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nrd1853","article-title":"Viral and cellular RNA helicases as antiviral targets","volume":"4","author":"Kwong","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1136\/gut.2005.076646","article-title":"Treating viral hepatitis C: efficacy, side effects, and complications","volume":"55","author":"Manns","year":"2006","journal-title":"Gut"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1056\/NEJMoa0806104","article-title":"Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection","volume":"360","author":"McHutchison","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jhep.2004.02.007","article-title":"Peginterferon alfa-2b plus ribavirin for treatment of chronic hepatitis C in previously untreated patients infected with HCV genotypes 2 or 3","volume":"40","author":"Zeuzem","year":"2004","journal-title":"J. Hepatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1478-3231.2010.02411.x","article-title":"New direct-acting antivirals\u2019 combination for the treatment of chronic hepatitis C","volume":"31","author":"Asselah","year":"2011","journal-title":"Liver Int."},{"key":"ref_15","first-page":"154","article-title":"Direct-acting antiviral medications for chronic hepatitis C virus infection","volume":"7","author":"Jazwinski","year":"2011","journal-title":"Gastroenterol. Hepatol. (NY)"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1365-2036.2010.04317.x","article-title":"Review article: specifically targeted anti-viral therapy for hepatitis C\u2014A new era in therapy","volume":"32","author":"Lange","year":"2010","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/nrgastro.2011.49","article-title":"A new standard of care for the treatment of chronic HCV infection","volume":"8","author":"Hofmann","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nbt.2020","article-title":"Discovery and development of telaprevir: An NS3-4A protease inhibitor for treating genotype 1 chronic hepatitis C virus","volume":"29","author":"Kwong","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/jac\/dkp388","article-title":"Viral resistance to specifically targeted antiviral therapies for hepatitis C (STAT-Cs)","volume":"65","author":"Kieffer","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2893.2009.01124.x","article-title":"Antiviral resistance and specifically targeted therapy for HCV (STAT-C)","volume":"16","author":"Thompson","year":"2009","journal-title":"J. Viral. Hepat."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1021\/bi901974a","article-title":"Mechanism and specificity of a symmetrical benzimidazolephenylcarboxamide helicase inhibitor","volume":"49","author":"Belon","year":"2010","journal-title":"Biochemistry"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"9637","DOI":"10.1021\/bi047437u","article-title":"Specific targeting of hepatitis C virus NS3 RNA helicase. Discovery of the potent and selective competitive nucleotide-mimicking inhibitor QU663","volume":"44","author":"Maga","year":"2005","journal-title":"Biochemistry"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"E239","DOI":"10.1007\/BF02854894","article-title":"Drug discovery from natural sources","volume":"8","author":"Chin","year":"2006","journal-title":"AAPS J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nrd1657","article-title":"The evolving role of natural products in drug discovery","volume":"4","author":"Koehn","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1126\/science.1168243","article-title":"Drug discovery and natural products: End of an era or an endless frontier?","volume":"325","author":"Li","year":"2009","journal-title":"Science"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1053\/j.gastro.2009.11.053","article-title":"Silibinin and related compounds are direct inhibitors of hepatitis C virus RNA-dependent RNA polymerase","volume":"138","author":"Ahnou","year":"2010","journal-title":"Gastroenterology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1002\/hep.23587","article-title":"Multiple effects of silymarin on the hepatitis C virus lifecycle","volume":"51","author":"Wagoner","year":"2010","journal-title":"Hepatology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/hep.24610","article-title":"The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry","volume":"54","author":"Ciesek","year":"2011","journal-title":"Hepatology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"21165","DOI":"10.1074\/jbc.M109.004945","article-title":"Proanthocyanidin from blueberry leaves suppresses expression of subgenomic hepatitis C virus RNA","volume":"284","author":"Takeshita","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1473-3099(03)00655-8","article-title":"Marine natural products and their potential applications as anti-infective agents","volume":"3","author":"Donia","year":"2003","journal-title":"Lancet Infect. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nrd2487","article-title":"Drug development from marine natural products","volume":"8","author":"Molinski","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.tips.2010.02.005","article-title":"The odyssey of marine pharmaceuticals: A current pipeline perspective","volume":"31","author":"Mayer","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/sj.embor.embor840","article-title":"Inhibition of intracellular hepatitis C virus replication by synthetic and vector-derived small interfering RNAs","volume":"4","author":"Yokota","year":"2003","journal-title":"EMBO Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1099\/vir.0.18997-0","article-title":"Hepatitis C virus RNA replication is resistant to tumour necrosis factor-alpha","volume":"84","author":"Frese","year":"2003","journal-title":"J. Virol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.bbrc.2005.02.138","article-title":"Efficient replication of a full-length hepatitis C virus genome, strain O, in cell culture, and development of a luciferase reporter system","volume":"329","author":"Ikeda","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1126\/science.290.5498.1972","article-title":"Efficient initiation of HCV RNA replication in cell culture","volume":"290","author":"Blight","year":"2000","journal-title":"Science"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"8516","DOI":"10.1128\/JVI.75.18.8516-8523.2001","article-title":"Effect of alpha interferon on the hepatitis C virus replicon","volume":"75","author":"Guo","year":"2001","journal-title":"J. Virol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.bbrc.2009.01.020","article-title":"High-throughput screening assay of hepatitis C virus helicase inhibitors using fluorescence-quenching phenomenon","volume":"379","author":"Tani","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1128\/JVI.72.8.6758-6769.1998","article-title":"Multiple enzymatic activities associated with recombinant NS3 protein of hepatitis C virus","volume":"72","author":"Gallinari","year":"1998","journal-title":"J. Virol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"12810","DOI":"10.1074\/jbc.M200182200","article-title":"The ATPase, RNA unwinding, and RNA binding activities of recombinant p68 RNA helicas","volume":"277","author":"Huang","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/j.1872-034X.2008.00352.x","article-title":"Griseofulvin, an oral antifungal agent, suppresses hepatitis C virus replication in vitro","volume":"38","author":"Jin","year":"2008","journal-title":"Hepatol. Res."}],"container-title":["Marine Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-3397\/10\/4\/744\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:49:36Z","timestamp":1760219376000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-3397\/10\/4\/744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,28]]},"references-count":41,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2012,4]]}},"alternative-id":["md10040744"],"URL":"https:\/\/doi.org\/10.3390\/md10040744","relation":{},"ISSN":["1660-3397"],"issn-type":[{"value":"1660-3397","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,28]]}}}